- The CDS is responsible for optimizing patient outcomes and utilization of B+L premium IOLs by transferring clinical knowledge and valuable skillsets to both surgeon and staff to develop all customers into successful users of our technology.
- Introduce pre-operative clinical protocol to interested premium IOL accounts via initial services
- Attend surgery to train surgeon and verify proper surgical technique of our premium IOLs
- Attend critical post ops and educate patients to establish optimal outcomes with our premium IOLs
- Use marketing tools/Panorama in the practice setting to integrate premium IOL usage, adopt best practices and maximize customer experience
- Assist surgeons and staff with premium IOL verifications using our B+L IDVS portal
- Secure & grow premium IOL business by working closely with B+L team members
- Strategically assist the IOL sales force to grow entire B+L surgical portfolio
- Strategically assist the Victus specialists to drive conversion and increase usage through practice development and education
- Understand key business drivers; use sales analytics and sales reporting to monitor surgeon usage in territory
- Provide assistance for B+L customers via telephone and email
- Build confidence and credibility around our people and our products
- Stay current with industry knowledge and participate in B+L team calls
- At least five years of experience as an Ophthalmic Technician, Optometrist, or Ophthalmologist with an emphasis in the area of cataract evaluation and surgery.
- Preferred three years of experience in pre-operative measurements (keratometry, corneal topography, and axial length measurement), IOL power calculations, cataract surgery and post-op care.
- Preferred three years of experience in an ophthalmic industry setting with an emphasis on clinical work related to cataract and/or corneal refractive surgery.
- Must be willing to travel 50% within territory to include some weekends.
Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed